Early posttransplant plasma ADAMTS13 activity reduction in stem cell transplantation: a prospective study of 46 pediatric patients

Bone Marrow Transplant. 2019 Dec;54(12):1926-1929. doi: 10.1038/s41409-019-0506-4. Epub 2019 Mar 19.

Authors

Kenji Kishimoto¹, Daiichiro Hasegawa², Keiichiro Kawasaki³, Akihiro Tamura², Nobuyuki Yamamoto², Atsuro Saito², Aiko Kozaki², Toshiaki Ishida², Yoshiyuki Kosaka²

Affiliations

¹ Department of Hematology and Oncology, Children's Cancer Center, Kobe Children's Hospital, Kobe, Japan. ken@yacht.ocn.ne.jp.
² Department of Hematology and Oncology, Children's Cancer Center, Kobe Children's Hospital, Kobe, Japan.
³ Department of Pediatrics, Kita-Harima Medical Center, Ichibacho, Ono, Japan.

PMID: 30890772
DOI: 10.1038/s41409-019-0506-4

No abstract available

Publication types

Letter

MeSH terms

ADAMTS13 Protein / metabolism*
Adolescent
Child
Child, Preschool
Female
Humans
Infant
Infant, Newborn
Male
Prospective Studies
Stem Cell Transplantation / methods*

Substances

ADAMTS13 Protein
ADAMTS13 protein, human